Vet and pet care specialist Greencross
(ASX:GXL) has seen a dip in full-year net profit as a result of writedowns but underlying sales have improved.
Underlying EBITDA is $97.6 million – that’s in line with guidance.
Statutory NPAT of $20.7 million.
EBITDA attributable to the owners of Greencross is down 25 per cent $74.8 million from $99.8 million.
Final fully franked dividend of 5.5 cents per share.
Shares in Greencross
(ASX:GXL) is up 5.79 per cent to $4.48
